Our Research
NexusMed.ai works to understand, predict, and prevent Adverse Drug Reactions (ADRs), bringing together large-scale pharmacovigilance data, advanced information retrieval, and clinical expertise. Our central focus is structured and unstructured ADR outcome predictions — forecasting the severity and clinical trajectory of adverse events at System Organ Class (SOC) level — where we confront the challenges of unstructured case narratives and the limitations of today's benchmarks.
We leverage retrieval as a first-class component of prediction. Rather than relying on model parameters alone, we ground every prediction in evidence drawn from real-world safety reports. Our mission is to strengthen patient safety and support informed prescribing by surfacing the hidden patterns within drug safety data.
Current Projects
Our Team
Collaborations
We are looking for partners with academic groups, clinicians, and regulatory-science teams on drug safety and retrieval-augmented AI. We welcome new collaborations across pharmacovigilance data sharing, clinical validation, and methods research. If you would like to be a part of these efforts, please get in touch.
Selected Publications
- David Guo, Nishant Vishwamitra, and Kim-Kwang Raymond Choo. Attention-Weighted Retrieval-Augmented Data Engineering for ADR Severity Classification. EMNLP Industry Track, 2026. Github Repo
- David Guo and Kim-Kwang Raymond Choo. Applications of Federated Large Language Models for Adverse Drug Reactions Prediction: A Scoping Review. Journal of Medical Internet Research, 2025.
Demo
Explore Retrieval-Augmented Knowledge Graph for ADR Prediction Framework (Access Upon Request)
Contact Us
Email: contact@nexusmed.ai
Affiliated Organization: College of AI, Cyber and Computing @ UTSA
Donations
NexusMed.ai is a non-profit academic research organization sustained by donations, which primarily fund the computing and open-source development behind our projects. We welcome support in many forms, including cash, computing hardware (e.g., GPUs), and cloud credits. Ongoing contributions from a broad base of supporters are essential to our progress and to maintaining our public charity status. To learn more about sponsorship opportunities and benefits, please contact Dr. David Guo.